Pharma

Pharmalot By Ed Silverman

FDA is rebuked by a federal agency for downgrading serious concerns over plant inspections

Pharmalot By Ed Silverman

Pharmalittle: 15 million doses of J&J Covid-19 vaccine ruined by ‘human error’; Bristol Myers fights U.S. over a $1.4 billion tax bill

Pharmalot By Ed Silverman

The U.S. government doesn’t have patent rights to Gilead’s remdesivir, despite investing millions in research

Pharmalot By Ed Silverman

Pharmalittle: Pfizer says Covid-19 shot is safe and effective in adolescents; FTC wants to block another Illumina deal

Pharmalot By Ed Silverman

FTC seeks to block Illumina from buying Grail, citing threats to competition

Pharmalot By Ed Silverman

Most U.S. universities get an ‘F’ on ensuring access to drugs they discover

Pharmalot By Ed Silverman

Pharmalittle: Pfizer and BioNTech to boost Covid-19 vaccine production; lawmakers ask FTC to probe insulin pricing

Pharmalot By Ed Silverman

Canadian company pursues compulsory license to distribute Covid-19 vaccine to low-income countries

Pharmalot By Ed Silverman

Congressional lawmakers urge FTC to investigate insulin makers over their pricing

Pharmalot By Ed Silverman

Pharmalittle: White House eyes suspending patent rights on Covid-19 vaccines; J&J supplier may be a vaccine bottleneck

Pharmalot By Ed Silverman

Former top Lilly lobbyist sues the company for alleged sex discrimination and harassment

First Opinion By Marvin D. Seppala

Money from opioid lawsuits is urgently needed now

Pharmalot By Ed Silverman

Canada says drug spending keeps rising due to increasingly expensive specialty meds

Pharmalot By Ed Silverman

Up and down the ladder: The latest comings and goings

Pharmalot By Ed Silverman

Pharmalittle: Novavax faces raw-materials shortages for Covid-19 shot; India curbs vaccine exports

Pharmalot By Ed Silverman

With time running out, an ALS patient fights with Biogen over expanded access to its drug

Pharmalot By Ed Silverman

EPA rule that could help citrus growers is challenged over concerns about antibiotic resistance

Pharmalot By Ed Silverman

HHS is urged to use its patents for the Moderna Covid-19 vaccine to widen global access

Pharmalot By Ed Silverman

Pharmalittle: AstraZeneca revises Covid-19 vaccine effectiveness; contractors grab a big slice of vaccine revenues

Pharma By Olivia Goldhill

Behind the scenes, companies helping big Covid-19 vaccine makers are getting rich

Health By Matthew Herper

Pushing back against U.S. health officials, AstraZeneca says new analysis confirms efficacy of its Covid-19 vaccine

Pharmalot By Ed Silverman

Pfizer hopes for a happy ending for an osteoarthritis drug with a troubled history

Pharmalot By Ed Silverman

Universities launch opioid litigation archive to ‘ensure history doesn’t repeat itself’

Pharmalot By Ed Silverman

Pharmalittle: Europe moves to curb Covid-19 vaccine exports; Slaoui fired from Galvani board over sexual harassment claim

Pharma By Matthew Herper

Moncef Slaoui, former head of Operation Warp Speed, fired from company board over sexual harassment allegations

Opinions+ By Krishanu Saha

A Biden-Harris Biomanufacturing Initiative could increase supplies of vaccines, therapeutics in one fell swoop

Pharma By Matthew Herper and Damian Garde

After leading a corporate turnaround, a swashbuckling CEO flies AstraZeneca into turbulence

Pharmalot By Ed Silverman

AbbVie accuses a company of recruiting an employee in order to steal Humira secrets

Pharmalot By Ed Silverman

Pharmalittle: AstraZeneca may have used ‘outdated’ info about its Covid-19 shot; Democrats eye drug-pricing measures